Results 11 to 20 of about 612,998 (297)

Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry

open access: yesWorld Allergy Organization Journal, 2023
Background: Although beta-lactams are 1 of the major causative agents of severe cutaneous adverse reactions (SCAR), their epidemiology and clinical aspects have been poorly studied.
Min-Hye Kim, MD, PhD   +16 more
doaj   +1 more source

Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing [PDF]

open access: yes, 2022
The increasing threat of drug resistance and a stagnated pipeline of novel therapeutics endanger the eradication of tuberculosis. Beta-lactams constitute promising additions to the current therapeutic arsenal and two carbapenems are included in group C ...
Olivença, Francisco   +8 more
core   +1 more source

Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus

open access: yesFrontiers in Molecular Biosciences, 2021
Methicillin-resistant S. aureus (MRSA) are resistant to beta-lactams, but synergistic activity between beta-lactams and glycopeptides/lipopeptides is common.
Rutan Zhang   +9 more
doaj   +1 more source

Which Are the Best Regimens of Broad-Spectrum Beta-Lactam Antibiotics in Burn Patients? A Systematic Review of Evidence from Pharmacology Studies

open access: yesAntibiotics, 2023
Background: Burn injury causes profound pathophysiological changes in the pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics. Infections are among the principal complications after burn injuries, and broad-spectrum beta-lactams are the ...
Gianpiero Tebano   +6 more
doaj   +1 more source

Characterization and molecular epidemiology of Staphylococcus aureus strains resistant to beta-lactams isolated from the milk of cows diagnosed with subclinical mastitis [PDF]

open access: yesVeterinary World, 2019
Background and Aim: The term ESKAPE, recognized by the WHO, is an acronym, which refers to the pathogens Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp., which is ...
Geziella Áurea Aparecida Damasceno Souza   +6 more
doaj   +1 more source

Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2019
The potential use of clinically approved beta-lactams for Buruli ulcer (BU) treatment was investigated with representative classes analyzed in vitro for activity against Mycobacterium ulcerans.
María Pilar Arenaz-Callao   +5 more
doaj   +1 more source

Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina

open access: yesRevista Panamericana de Salud Pública, 2021
Objective. To describe bacterial resistance and antimicrobial consumption ratio at the subnational level in Argentina during 2018, considering beta-lactams group as a case-study. Methods.
Silvia Boni   +8 more
doaj   +1 more source

Patterns and outcomes of empirical antimicrobial use in elderly outpatients: A pilot observational study from North India

open access: yesJournal of the Indian Academy of Geriatrics, 2022
Introduction: Despite the rampant use of antimicrobials in health-care settings, the safety and clinical outcome data of antimicrobials are scarce in the elderly population.
Bisweswar Ojha   +3 more
doaj   +1 more source

Isothiourea-catalyzed asymmetric synthesis of β-lactams and β-amino esters from arylacetic acid derivatives and N-sulfonylaldimines [PDF]

open access: yes, 2014
This work is supported by a Royal Society for a University Research Fellowship and the EPSRC and GSK (Case Award) as well as by the European Research Council under the European Unionʼs Seventh Framework Programme (FP7/2007-2013) (ERC Grant Agreement No ...
Prevet, Hugues   +5 more
core   +1 more source

Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study

open access: yesBMC Infectious Diseases, 2022
Background Recent studies demonstrated that failure of achieving pharmacodynamic targets of commonly used antibiotics is common in critically ill patients.
Tim M. J. Ewoldt   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy